Literature DB >> 2424452

Stimulation in vitro of expression of the amp gene of pBR322 by soluble protein fractions isolated from E. coli.

Y Kuriki.   

Abstract

Two soluble protein fractions isolated from E. coli were found to be required for efficient expression of the amp gene of pBR322 in an in vitro coupled transcription-translation system consisting of unwashed ribosomes and a polyethylene glycol-treated S30 extract from E. coli. Both fractions stimulated the pBR322-directed synthesis of the amp gene product, pre-beta-lactamase, in the in vitro system. However, pBR322-directed RNA synthesis was stimulated only by one fraction. It is therefore likely that one fraction enhances the transcription of the amp gene and the other is involved mainly in stimulation of the translation of pre-beta-lactamase mRNA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424452

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  5 in total

1.  Response to temperature shifts of expression of the amp gene on pBR322 in Escherichia coli K-12.

Authors:  Y Kuriki
Journal:  J Bacteriol       Date:  1987-05       Impact factor: 3.490

2.  Requirement of a heat-labile factor(s) for in vitro expression of the amp gene of pBR322.

Authors:  Y Kuriki
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

3.  The translation start signal region of TEM beta-lactamase mRNA is responsible for heat shock-induced repression of amp gene expression in Escherichia coli.

Authors:  Y Kuriki
Journal:  J Bacteriol       Date:  1989-10       Impact factor: 3.490

4.  Discovery and analysis of 4H-pyridopyrimidines, a class of selective bacterial protein synthesis inhibitors.

Authors:  Wendy Ribble; Walter E Hill; Urs A Ochsner; Thale C Jarvis; Joseph W Guiles; Nebojsa Janjic; James M Bullard
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

5.  A comparative study of protein synthesis in in vitro systems: from the prokaryotic reconstituted to the eukaryotic extract-based.

Authors:  Jason R Hillebrecht; Shaorong Chong
Journal:  BMC Biotechnol       Date:  2008-07-29       Impact factor: 2.563

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.